Literature DB >> 23068151

Emerging systemic fungal infections.

Ricardo Galimberti1, Ana Clara Torre, María Carolina Baztán, Florencia Rodriguez-Chiappetta.   

Abstract

Systemic mycoses are a heterogeneous group of infections caused by different species of fungi that mainly affect individuals with primary or secondary alterations of immunity. In recent years, there has been an increase in the incidence of infections related to migration, AIDS, and other causes of immunosuppression, such as solid organ and bone marrow transplantation; oncological, hematological, and autoimmune diseases; and the use of new drugs. In this paper, we outline the microbiological and epidemiological characteristics of 3 fungi: Aspergillus spp, Fusarium spp, and Penicillium spp. We describe the clinical manifestations of disease with emphasis on those that should alert the dermatologist to make an early diagnosis. We detail the various tools for early diagnosis, prevention, and the epidemiology of different antifungals available for treatment and their mechanism of action and therapeutic efficacy.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23068151     DOI: 10.1016/j.clindermatol.2012.01.011

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  15 in total

Review 1.  The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.

Authors:  Xiaolei Wei; Yuanwei Zhang; Ling Lu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

2.  Occult Fungal Scleritis.

Authors:  Lauren J Jeang; Aaron Davis; Brian Madow; Edgar M Espana; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2016-09-14

3.  Comparison of DNA Microarray, Loop-Mediated Isothermal Amplification (LAMP) and Real-Time PCR with DNA Sequencing for Identification of Fusarium spp. Obtained from Patients with Hematologic Malignancies.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Kanae Sakai; Yasunori Muraosa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Anna Sara Shafferman Levin; Angélica Zaninelli Schreiber; Yuzuru Mikami; Tohoru Gonoi; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Mycopathologia       Date:  2017-03-21       Impact factor: 2.574

Review 4.  Bioprospecting Sponge-Associated Microbes for Antimicrobial Compounds.

Authors:  Anak Agung Gede Indraningrat; Hauke Smidt; Detmer Sipkema
Journal:  Mar Drugs       Date:  2016-05-02       Impact factor: 5.118

5.  Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design.

Authors:  Mark F Mabanglo; Michael A Hast; Nathan B Lubock; Homme W Hellinga; Lorena S Beese
Journal:  Protein Sci       Date:  2014-01-31       Impact factor: 6.725

6.  Retrospective analysis of 15 cases of Penicilliosis marneffei in a southern China hospital.

Authors:  Fengli Zhou; Xiaogang Bi; Xiaoling Zou; Zhiyang Xu; Tiantuo Zhang
Journal:  Mycopathologia       Date:  2014-04-09       Impact factor: 3.785

7.  Fatal disseminated fusarium infection in a human immunodeficiency virus positive patient.

Authors:  Ashwini K Esnakula; Irorere Summers; Tammey J Naab
Journal:  Case Rep Infect Dis       Date:  2013-05-13

8.  Interactions between a sap beetle, sabal palm, scale insect, filamentous fungi and yeast, with discovery of potential antifungal compounds.

Authors:  Andrew R Cline; Paul E Skelley; Scott A Kinnee; Suzanne Rooney-Latham; Shaun L Winterton; Christopher J Borkent; Paolo Audisio
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

9.  Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests.

Authors:  Marcela de Souza; Tetsuhiro Matsuzawa; Luzia Lyra; Ariane Fidelis Busso-Lopes; Tohru Gonoi; Angélica Zaninele Schreiber; Katsuhiko Kamei; Maria Luiza Moretti; Plínio Trabasso
Journal:  Springerplus       Date:  2014-08-30

10.  Similar efficacy of broad-range ITS PCR and conventional fungal culture for diagnosing fungal infections in non-immunocompromised patients.

Authors:  Silvana K Rampini; Andrea Zbinden; Roberto F Speck; Guido V Bloemberg
Journal:  BMC Microbiol       Date:  2016-06-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.